Annual report [Section 13 and 15(d), not S-K Item 405]

Divestitures - Key Components of Net (Loss) Income from Discontinued Operations (Details)

v3.25.4
Divestitures - Key Components of Net (Loss) Income from Discontinued Operations (Details) - USD ($)
3 Months Ended 12 Months Ended
Dec. 31, 2025
Sep. 30, 2025
Jun. 30, 2025
Mar. 31, 2025
Dec. 31, 2024
Sep. 30, 2024
Jun. 30, 2024
Mar. 31, 2024
Dec. 31, 2025
Dec. 31, 2024
Cost of revenues:                    
Income (loss) before income tax expense $ (224,068) $ 664,269 $ 1,183,199 $ 1,577,229 $ (1,075,745) $ (2,693,562) $ (1,719,222) $ 1,516,243 $ 3,200,629 $ (3,972,286)
Income tax expense from discontinued operations (278,036) 99,630 100,201 103,412 (184,429) 57,194 167,153 170,345 25,207 210,263
Net income (loss) from discontinued operations $ 53,968 $ 564,639 $ 1,082,998 $ 1,473,817 $ (891,316) $ (2,750,756) $ (1,886,375) $ 1,345,898 3,175,422 (4,182,549)
Corporate Clinics                    
Cost of revenues:                    
Income tax expense from discontinued operations                 25,207 210,263
Net income (loss) from discontinued operations                 3,175,422 (4,182,549)
Discontinued Operations, Held-for-Sale or Disposed of by Sale | Corporate Clinics                    
Revenues:                    
Total revenues                 54,038,508 69,982,344
Cost of revenues:                    
Total cost of revenues                 20,971 47,817
Selling and marketing expenses                 5,755,830 7,850,616
Depreciation and amortization                 69,558 3,350,748
General and administrative expenses                 39,450,918 54,988,780
Total selling, general and administrative expenses                 45,276,306 66,190,144
Net loss on disposition or impairment from discontinued operations                 5,441,010 7,714,555
Income (loss) from discontinued operations                 3,300,221 (3,970,172)
Other expense, net                 99,592 2,114
Income (loss) before income tax expense                 $ 3,200,629 $ (3,972,286)